Literature DB >> 925886

Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.

J G Wagner, J W Ayres.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 925886     DOI: 10.1007/bf01061733

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


× No keyword cloud information.
  24 in total

1.  Comparative bioavailabilities from truncated blood level curves.

Authors:  E G Lovering; I J McGilveray; I McMillan; W Tostowaryk
Journal:  J Pharm Sci       Date:  1975-09       Impact factor: 3.534

2.  Biased bioavailability estimates.

Authors:  P H Hinderling
Journal:  J Pharm Sci       Date:  1976-07       Impact factor: 3.534

3.  Bioavailability of digoxin tablets and elixir in the fasting and postprandial states.

Authors:  D J Greenblatt; D W Duhme; J Koch-Weser; T W Smith
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

4.  Curve fitting by spline and Akima methods: possibility of interpolation error and its suppression.

Authors:  J Fried; S Zietz
Journal:  Phys Med Biol       Date:  1973-07       Impact factor: 3.609

5.  Absorption of orally given digoxin preparations.

Authors:  D H Huffman; D L Azarnoff
Journal:  JAMA       Date:  1972-11-20       Impact factor: 56.272

6.  Pharmacokinetics of digoxin: interpreting bioavailability.

Authors:  N Sanchez; L B Sheiner; H Halkin; K L Melmon
Journal:  Br Med J       Date:  1973-10-20

7.  An overview of the analysis and interpretation of bioavailability studies in man.

Authors:  J G Wagner
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

8.  Digoxin bioavailability: formulations and rates of infusions.

Authors:  F I Marcus; J Dickerson; S Pippin; M Stafford; R Bressler
Journal:  Clin Pharmacol Ther       Date:  1976-09       Impact factor: 6.875

9.  Bioavailability studies with Digoxin-Sandoz and Lanoxin.

Authors:  T Beveridge; F Kalberer; E Nüesch; R Schmidt
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

10.  Biological availability of digoxin from Lanoxin produced in the United Kingdom.

Authors:  B F Johnson; A S Fowle; S Lader; J Fox; A D Munro-Faure
Journal:  Br Med J       Date:  1973-11-10
View more
  12 in total

1.  Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data.

Authors:  Viera Lukacova; Walter S Woltosz; Michael B Bolger
Journal:  AAPS J       Date:  2009-05-09       Impact factor: 4.009

2.  Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.

Authors:  J G Wagner; R G Stoll; D J Weidler; J W Ayres; M R Hallmark; E Sakmar; A Yacobi
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

3.  Optimal design allocations for estimating area under curves for studies employing destructive sampling.

Authors:  W W Piegorsch; A J Bailer
Journal:  J Pharmacokinet Biopharm       Date:  1989-08

4.  Organophosphorus pesticide degradation product in vitro metabolic stability and time-course uptake and elimination in rats following oral and intravenous dosing.

Authors:  N D Forsberg; R Rodriguez-Proteau; L Ma; J Morré; J M Christensen; C S Maier; J J Jenkins; K A Anderson
Journal:  Xenobiotica       Date:  2011-03-29       Impact factor: 1.908

5.  Sampling strategies for noncompartmental estimation of mean residence time.

Authors:  D Z D'Argenio; D Katz
Journal:  J Pharmacokinet Biopharm       Date:  1983-08

6.  A method to predict infinity values for biexponential processes.

Authors:  J Newburger; J G Wagner; S Stavchansky
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

7.  Time to reach steady state and prediction of steady-state concentrations for drugs obeying Michaelis-Menten elimination kinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

8.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

9.  Evidence of nonlinearity in digoxin pharmacokinetics.

Authors:  J G Wagner; K D Popat; S K Das; E Sakmar; H Movahhed
Journal:  J Pharmacokinet Biopharm       Date:  1981-04

10.  Steroid metabolism in isolated rat hepatocytes.

Authors:  J A Morais; J G Wagner
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Oct-Dec       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.